Recent News

• 10.01.2025 - Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia
• 10.01.2025 - Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia
• 09.18.2025 - Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium
• 09.18.2025 - Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium
• 09.08.2025 - Adagio Medical Expands Chief Business Officer Deborah Kaster’s Role to Include Chief Financial Officer Responsibilities
• 09.08.2025 - Adagio Medical Expands Chief Business Officer Deborah Kaster’s Role to Include Chief Financial Officer Responsibilities

Recent Filings

• 10.01.2025 - EX-99.1 EX-99.1
• 10.01.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 10.01.2025 - 8-K Current report
• 10.01.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 09.30.2025 - 3 Initial statement of beneficial ownership of securities
• 09.08.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 09.08.2025 - 8-K Current report
• 09.08.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 09.08.2025 - EX-99.1 EX-99.1
• 08.26.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors